Matrix Metalloproteinases
- Name
- Matrix Metalloproteinases
- Accession Number
- DBCAT001783
- Description
Not Available
- Drugs
Drug Drug Description Tanomastat Investigated for use/treatment in pancreatic cancer, lung cancer, ovarian cancer, and osteoarthritis. Rebimastat Investigated for use/treatment in lung cancer and prostate cancer. - Drugs & Drug Targets
Drug Target Type Tanomastat 72 kDa type IV collagenase target